[1]
J. Spergel, “Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Comorbid Allergic Rhinitis”, J of Skin, vol. 5, no. 1, p. s13, Jan. 2021.